Pharmafile Logo

Digital Therapeutics Landscape in Europe

September 3, 2020 |  

OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

Digital Therapeutics Landscape in Europe: The Case of Germany and the UK

The COVID-19 virus crisis has opened immense windows of opportunity in healthcare around the globe. One of the greatest opportunities is in digital health, and in particular, digital therapeutics (DTx). The need for continued medical care combined with social distancing has led to a spike in use of digital health tools worldwide.1 As the interest in and use of digital health has grown during this period, we anticipate that investments in digital health tools will continue to accelerate after the COVID-19 pandemic. When the COVID-19 outbreak started, millions of Chinese people turned to online doctors and online health tools1 to find the needed support for their health. While these developments could create new risks for privacy and data protection, they also represent an unprecedented opportunity to integrate industry 4.0 in healthcare for the benefit of patients.

HIGHLIGHTS INCLUDE:
  • Opportunities and threats of digital therapeutics after COVID-19
  • Digital therapeutics landscape in the European Union
  • Review and comparison of the German and UK therapeutics landscape
  • Develop game-changing insights and competitive advantage on both a global and local scalepi

Pink divider

Download the white paper and learn how it’s happening now!

Download the Paper- PMLiVE

  1. https://www.cnbc.com/2020/03/26/investments-in-digital-health-care-could-accelerate-after-coronavirus-credit-suisse-says.html

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN Health at the World Orphan Drug Conference USA

Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !

OPEN Health Medical Communications is awarded Medical Affairs Agency of The Year at the Communiqué Awards 2020

We are delighted to announce that OPEN Health Medical Communications was named Medical Affairs Agency of the Year at the virtual 2020 Communiqué Awards ceremony on 02 July 2020.

Candice Subero to Lead Global Marketing for OPEN Health

OPEN Health is pleased to announce that Candice Subero has been named Global Marketing Lead, effective June 4, 2020. Candice will oversee strategic communications and marketing efforts across all OPEN...

The RARE Youth Revolution has begun

OPEN Health are proud to support RARE Revolution Magazine who have launched a dedicated RARE youth online platform powering up the voices of the youth rare disease community.

Jeff Anderson joins OPEN Health as European Lead for OPEN VIE and Pharmerit

OPEN Health, the family of expert practices working in partnership to drive positive change in healthcare communications and market access, has appointed Jeff Anderson as European Lead for the combined...

OPEN Health Webinar – Succeeding with Star Wars Medicine

Summary of their recently published white paper on gene therapy followed by a Q&A session on 12th June 2020. Book now!

Yurie Oates, Account Director, OPEN Health gives us some Top tips from 5 years of account management on #MedCommsDay

WHAT IS ACCOUNT MANAGEMENT?Account/project managers support the day-to-day running of their account: they are the glue in a team who make sure projects are completed on brief, on time and...

A day in the life of an Associate Publications Director

Eleanor Raynsford, Associate Publications Director, OPEN Health gives us an insight into a day in the life of her role.

Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19

Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time.